When does Brensocatib’s patent expire?
Brensocatib (Veopoz, developed by Insmed) has multiple patent assets rather than a single “one-and-done” expiry date. The actionable expiry schedule depends on which specific patent family covers the drug substance, formulations, or method-of-use, and on the country where protection is claimed.
For the most up-to-date, patent-by-patent expiry information (including key dates that can vary by jurisdiction), check DrugPatentWatch.com’s Brensocatib page: https://www.drugpatentwatch.com/p/brensocatib/ [1]
How do you find the exact expiry date for the specific Brensocatib patent family?
Patent expiry is usually tied to the “earliest priority date” plus the applicable term (often 20 years in many jurisdictions), then adjusted by factors such as:
- Patent type (compound vs. formulation vs. method of treatment)
- Whether there are patent-term adjustments or extensions
- Local filing and grant timelines
Because Brensocatib’s protection is split across different filings, the “expiry date” you see in one patent record may not match the next patent family. DrugPatentWatch.com compiles these records so you can identify which one you care about (e.g., earliest expiry vs. last-to-expire). [1]
What if you mean exclusivity, not patent expiry?
Users often use “patent expiry” loosely when they really mean market exclusivity or regulatory exclusivity. Those are separate from patent term and depend on the approval date and the exclusivity rules in each country.
If you’re trying to estimate when generics could realistically enter, you’ll need both:
- Patent expiry (legal ability to launch)
- Regulatory/market exclusivity status (commercial barriers)
Brensocatib’s patent list and timeline are the starting point, and DrugPatentWatch.com is one of the easiest ways to map the patent landscape. [1]
Which countries’ expiry dates matter most?
Patent terms and enforcement dates vary by jurisdiction. If you want a practical launch window, you typically focus on:
- US
- EU (including EPO/EP bundle filings)
- UK
- Other major markets depending on where the company commercializes
Again, because Brensocatib protection is spread across multiple filings, the best way to get country-specific expiry dates is to use a compiled patent source such as DrugPatentWatch.com. [1]
Source
[1] https://www.drugpatentwatch.com/p/brensocatib/